Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03796286 · ClinicalTrials.gov registry record · NA
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses
A NA study of Insulin Sensitivity and Blood Glucose, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 2
- Study locations
NCT03796286: Completed NA study of Insulin Sensitivity and Blood Glucose, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
NCT03796286 is a NA study of Insulin Sensitivity and Blood Glucose that has completed, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 41 participants, below the 71-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03796286, a NA study of Insulin Sensitivity and Blood Glucose, has completed, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 2
- Study locations
Study Summary
This randomized, crossover study will include four clinic visits: one screening (day -7) and three test visits (days 0, 2, 4). The objective of this study is to assess the effects of dietary fiber-containing bars, at two doses of fiber, compared to a control product, on postprandial glucose and insulin responses in healthy adult men and women.
Primary Outcome
Differences between the dietary fiber and control conditions following a breakfast meal tolerance test (MTT) completed at visits 2, 3, and 4 in the incremental AUC (iAUC) from pre-breakfast intake to 2 hours post breakfast intake for capillary glucose.
Conditions Studied
Interventions
- OTHER Medium-fiber bar
- OTHER High-fiber bar
- OTHER Control bar (0 g fiber)
Study Locations (2)
Florida
- MB Clinical Research - Boca Raton
Illinois
- Great Lakes Clinical Trials - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-12-14 |
| Est. Completion | 2019-02-27 |
| Phase | NA |
What the finished NCT03796286 record still lists
NCT03796286 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 71-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (42% lower).
The record links to 3 conditions, with Insulin Sensitivity appearing as the primary indexed condition, and to 3 interventions - of which Medium-fiber bar is the first listed.
NCT03796286 reports a single indexed study location in Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT03796286 about?
NCT03796286 is a clinical study titled "A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses". This randomized, crossover study will include four clinic visits: one screening (day -7) and three test visits (days 0, 2, 4). The objective of this study is to assess the effects of dietary fiber-containing bars, at two doses of fiber, compared to a control product, on postprandial glucose and insu...
What is the current status of trial NCT03796286?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2018-12-14. Estimated completion is 2019-02-27.
What conditions does trial NCT03796286 study?
This clinical trial studies the following conditions: Insulin Sensitivity, Blood Glucose, Dietary Fiber.
What interventions are being tested in trial NCT03796286?
The interventions under investigation include: Medium-fiber bar (OTHER), High-fiber bar (OTHER), Control bar (0 g fiber) (OTHER).
Who is sponsoring clinical trial NCT03796286?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03796286 being conducted?
This trial has 2 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03796286's enrollment target sits among peer trials
41 17th of 29 higher than 13 of 29 other Insulin Sensitivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Sensitivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Countermeasures to Circadian Misalignment
RECRUITING · NA
-
Effect of Pulsatile Hormone Administration on Insulin Action
RECRUITING · NA
-
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
RECRUITING · NA
-
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI